Deliver patient-specific reports for any NGS panel in minutes with on-demand, expert-curated content and professional interpretation services
Today’s health care industry is witnessing a paradigm shift that is driving a tighter integration of genomic analysis modalities in patient care decisions. From disease diagnostics and prognostics to carrier screening and clinical trial enrollment, physicians and oncologists are ordering a growing number of genetic tests for an expanding menu of applications.
QIAGEN Clinical Insights (QCI) offers expert-curated knowledge, software and services to support clinical NGS data analysis and interpretation for any indication, on your platform, in a fraction of the time.
You’re invited to QIAGEN Digital Insights’ annual Break the Data Bottleneck Summit, a free-to-attend, two-part virtual event exploring how diagnostic labs can lower the barrier to adopt large cancer genomic profiling.
A two-part event, the Break the Data Bottleneck Summit will explore how small to mid-sized clinical diagnostic labs can compete to offer comprehensive genomic profiling services for precision oncology with the same speed and confidence of hospital networks and university centers.
QIAGEN Clinical Insight (QCI) is an evidence-based decision support software intended as an aid in the interpretation of variants observed in genomic sequencing data. The software evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical-trials. Based on this evaluation, the software proposes a classification to aid in the interpretation of observed variants. The software is NOT intended as a primary diagnostic tool by physicians or to be used as a substitute for professional healthcare advice. Each laboratory is responsible for ensuring compliance with applicable international, national, and local clinical laboratory regulations and other specific accreditations requirements.